Mark MD - Onconova Therapeutics Chief Officer
| ONTXDelisted Stock | USD 1.02 0.04 3.77% |
Insider
Mark MD is Chief Officer of Onconova Therapeutics
| Age | 67 |
| Phone | 267 759 3680 |
| Web | https://www.onconova.com |
Onconova Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.3807) % which means that it has lost $0.3807 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.843) %, meaning that it created substantial loss on money invested by shareholders. Onconova Therapeutics' management efficiency ratios could be used to measure how well Onconova Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| MBA MBA | Ocugen Inc | 58 | |
| Mark Peikin | Adial Pharmaceuticals | N/A | |
| Carol Lizak | Jaguar Animal Health | 60 | |
| Catherine Fratila | Adial Pharmaceuticals | N/A | |
| Manuel Dafonseca | Sonnet Biotherapeutics Holdings | N/A | |
| Tiffany MBA | Ocugen Inc | N/A | |
| Louis Ploth | Moleculin Biotech | 70 | |
| Victoria Rac | Bio Path Holdings | N/A | |
| Susan Dexter | Sonnet Biotherapeutics Holdings | 69 | |
| Thomas Walker | Bio Path Holdings | N/A | |
| Michael Shine | Ocugen Inc | N/A | |
| CPA CPA | GeoVax Labs | 62 | |
| MBA CMA | Pulmatrix | 69 | |
| Donald Picker | Moleculin Biotech | 78 | |
| CPA CPA | Ocugen Inc | 47 | |
| Thomas III | Ibio Inc | 57 | |
| Jay Cross | Sonnet Biotherapeutics Holdings | 53 | |
| MBA MBA | Adial Pharmaceuticals | 46 | |
| Robert McRae | Palisade Bio | N/A | |
| Alex Lugovoy | Adial Pharmaceuticals | N/A | |
| FACP MD | Moleculin Biotech | 70 | |
Management Performance
| Return On Equity | -0.84 | |||
| Return On Asset | -0.38 |
Onconova Therapeutics Leadership Team
Elected by the shareholders, the Onconova Therapeutics' board of directors comprises two types of representatives: Onconova Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Onconova. The board's role is to monitor Onconova Therapeutics' management team and ensure that shareholders' interests are well served. Onconova Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Onconova Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark CPA, CFO COO | ||
| Victor MD, Chief Officer | ||
| Steven MD, President CEO | ||
| Mark MD, Chief Officer | ||
| Adar Silverstein, Sr Devel |
Onconova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Onconova Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.84 | |||
| Return On Asset | -0.38 | |||
| Operating Margin | (89.28) % | |||
| Current Valuation | (4.56 M) | |||
| Shares Outstanding | 21 M | |||
| Shares Owned By Insiders | 0.77 % | |||
| Shares Owned By Institutions | 7.95 % | |||
| Number Of Shares Shorted | 20.7 K | |||
| Price To Earning | (0.87) X | |||
| Price To Book | 1.43 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |